Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EDGE

Edge Therapeutics (EDGE) Stock Price, News & Analysis

Edge Therapeutics logo

About Edge Therapeutics Stock (NASDAQ:EDGE)

Advanced Chart

Key Stats

Today's Range
$39.95
$39.96
50-Day Range
$0.50
$6.71
52-Week Range
$0.28
$17.38
Volume
170 shs
Average Volume
373,201 shs
Market Capitalization
$1.26 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EDGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Edge Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

EDGE Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

EDGE Stock Analysis - Frequently Asked Questions

Edge Therapeutics, Inc. (NASDAQ:EDGE) posted its earnings results on Thursday, November, 1st. The biotechnology company reported ($0.11) earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $0.16.

Based on aggregate information from My MarketBeat watchlists, some other companies that Edge Therapeutics investors own include ContraFect (CFRX), McEwen Mining (MUX), Arena Pharmaceuticals (ARNA), BioLineRx (BLRX), Bristol Myers Squibb (BMY), Cerecor (CERC) and CRISPR Therapeutics (CRSP).

Company Calendar

Last Earnings
11/01/2018
Today
7/08/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:EDGE
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$40.86 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$0.95 per share
Price / Book
42.06

Miscellaneous

Free Float
N/A
Market Cap
$1.26 billion
Optionable
Not Optionable
Beta
3.65
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:EDGE) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners